- Home
- HAFN vs ALVO Comparison
HAFN vs ALVO Comparison
Compare HAFN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFN
- ALVO
- Stock Information
- Founded
- HAFN 2012
- ALVO 2013
- Country
- HAFN Singapore
- ALVO Luxembourg
- Employees
- HAFN N/A
- ALVO N/A
- Industry
- HAFN
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- HAFN
- ALVO Health Care
- Exchange
- HAFN Nasdaq
- ALVO Nasdaq
- Market Cap
- HAFN 2.9B
- ALVO 2.5B
- IPO Year
- HAFN N/A
- ALVO N/A
- Fundamental
- Price
- HAFN $6.28
- ALVO $5.58
- Analyst Decision
- HAFN Strong Buy
- ALVO Buy
- Analyst Count
- HAFN 1
- ALVO 2
- Target Price
- HAFN $6.50
- ALVO $11.00
- AVG Volume (30 Days)
- HAFN 1.1M
- ALVO 730.8K
- Earning Date
- HAFN 11-26-2025
- ALVO 11-12-2025
- Dividend Yield
- HAFN 10.06%
- ALVO N/A
- EPS Growth
- HAFN N/A
- ALVO N/A
- EPS
- HAFN 0.84
- ALVO 0.22
- Revenue
- HAFN $2,354,657,000.00
- ALVO $562,478,000.00
- Revenue This Year
- HAFN N/A
- ALVO $34.94
- Revenue Next Year
- HAFN N/A
- ALVO $39.55
- P/E Ratio
- HAFN $7.43
- ALVO $25.20
- Revenue Growth
- HAFN N/A
- ALVO 82.19
- 52 Week Low
- HAFN $3.61
- ALVO $4.70
- 52 Week High
- HAFN $6.44
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- HAFN 56.10
- ALVO 30.79
- Support Level
- HAFN $6.08
- ALVO $4.70
- Resistance Level
- HAFN $6.27
- ALVO $8.50
- Average True Range (ATR)
- HAFN 0.14
- ALVO 0.35
- MACD
- HAFN 0.00
- ALVO -0.27
- Stochastic Oscillator
- HAFN 72.65
- ALVO 20.39
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.